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Abstract
Hypoxia is a frequent characteristic of the solid tumor microenvironment, which occurs
when cancer cells lack adequate access to oxygen. By selecting for cells that can adapt to and
grow in low oxygen conditions, tumor hypoxia contributes to a more aggressive and invasive
cancer phenotype that portends a poor clinical outcome. While many aspects of the cellular
response to hypoxia have been explored, the roles of some factors have not been fully explained.
Cell signaling factors, including signal transducer and activator of transcription 3 (STAT3), the
mu opioid receptor (MOR), and the delta opioid receptor (DOR), as well as changes in the
mitochondrial membrane potential may play a role in cancer cell adaptation to hypoxia.
Importantly, the hypoxia-related actions of STAT3 and the human opioid receptors have not
been thoroughly researched within the context of human neuronal cancer cells. To investigate the
roles of these proteins in hypoxic adaptation, we developed and tested a model of chemically
induced hypoxia using neuronal cells. We administered the hypoxia mimetic, cobalt chloride, to
a human neuroblastoma cell line. The preliminary data of flow cytometry suggested that cobaltinduced hypoxia increased the total amount of STAT3 in neuroblastoma cells, but decreased the
amount of phosphorylated STAT3 in a time dependent pattern. The preliminary results using JC1 staining with confocal microscopy indicated that cobalt exposure did not change mitochondrial
membrane potential in surviving cells. RT-PCR (reverse transcription) analysis showed a
decrease in MOR expression and no change in DOR expression. This decrease in expression
lends support to an inhibitory role of MOR in neuronal adaptation to hypoxia. These results also
implicated that survival of neuronal cells under cobalt treatment likely are independent of
STAT3 tyrosine phosphorylation. Taken together this study provides a baseline for future use of
this model to investigate hypoxia.
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Introduction
Tumor hypoxia
Hypoxia is a common feature of the solid tumor microenvironment, in which cancer cells
and their local tissue do not have adequate access to oxygen. The causes and effects of tumor
hypoxia are multifaceted. Tumor hypoxia can be the result of at least three factors: irregular
tumor vasculature, increased proliferation of cancer cells, and/ or anemia (Vaupel & Harrison,
2004). Due to a deregulation of endothelial regulatory signals, tumor-adjacent vascular tissue is
often chaotically arranged and abnormally permeable (Baluk et al, 2005). These irregularities
preclude normal perfusion of oxygen into the tissue, and hypoxia occurs.
Tumor cells exist in a hyper-proliferative state. This state increases their demand for both
oxygen and nutrients, and when that demand outpaces the delivery capacity of existing blood
vessels, hypoxia (low oxygenation) results. In addition, the rapid pace of cancer cell growth
allows some tumor cells to grow beyond the distance that oxygen in tissue can diffuse to
(<100µm). Furthermore, chemotherapies and/or cancer cell signaling can reduce the capacity of
blood to transport oxygen (Ludwig, et al, 1995). Thus treatment- and tumor-induced anemias
cause the surrounding tissue to develop hypoxia. Within the tumor microenvironment, the
balance between normoxia (normal oxygenation) and hypoxia temporally shifts as a function of
the integration of hypoxia-inducing factors and hypoxia-response factors. As a result of this,
tumors develop a spatially heterogeneous map of hypoxic regions (Jiang et al, 2012). The core of
solid tumors tends to be anoxic and necrotic due to a complete lack of oxygen access. Cells more
towards the tumor periphery of the tumor have greater access to oxygen, and exhibit lower levels
of hypoxia (Evans et al, 2001; Evans et al, 2007).
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From a clinical perspective, hypoxic conditions within the tumor microenvironment have
been associated with resistance to cancer therapy, increased aggressiveness, invasiveness, and
metastasis (Ruan et al, 2009). And it has been well documented that killing hypoxic tumor cells
during cancer treatment requires an increased dosage of radiation as compared to normoxic
tumor cells (Coleman, 1988). Any or all of these associations add evidence to the observed
correlation between hypoxic tumors and poor clinical prognosis (Vaupel, 2008).
From a cellular perspective, hypoxia exerts selective pressure on a tumor cell population. The
fate of any tumor cell encountering this hypoxic pressure is determined not only by the severity
of hypoxia, but also by the cellular adaptability, which dictate whether the cell survives or
induces apoptosis. The majority of tumor cells that are subjected to hypoxia die, but some cells
are able to resist apoptosis and continue to proliferate. These surviving cells escape the constraint
of hypoxia, gain a competitive advantage over hypoxia-sensitive cells, and are able to clonally
expand; establishing colonies of tumor cells that persist under hypoxic conditions (Graeber et al,
1996).
Thus, hypoxia initiates an adverse cycle of tumor progression in which the
microenvironment selects for cells that are capable of surviving hypoxia and may further
promote proliferation and metastasis. Given the negative clinical implications of tumor hypoxia,
understanding how cancer cells adapt to it is paramount in understanding the pathogenesis of
cancer.

The cellular response to hypoxia
The cellular sensation of and response to hypoxia is mainly mediated through hypoxia
inducible factor (HIF), which is upregulated in response to low oxygen, and thus in many
cancers. HIF promotes the transcription of more than 100 downstream genes whose functions
9

include cell survival, proliferation, altered metabolism, and angiogenesis; processes that must be
initiated in order for a cell to survive hypoxic conditions (Masoud & Li, 2015). Cancer cells in
low oxygen regions of tumors can coopt this global hypoxia response system to ensure their
survival and proliferation.
Independently or in cooperation with HIF, signal transducer and activator of transcription
3 (STAT3) may also play a role in the tumor cell adaptation to hypoxia. STAT3 is a latent
cytoplasmic transcription factor that translocates to the nucleus to regulate gene expression,
including the expression of many oncogenic proteins (Yu et al, 2009). The role of STAT3 in
regulating the transcription of key oncogenes and its connection to various serine and tyrosine
kinases suggest that STAT3 is a shared signaling node between several pathways, which all
contribute to tumorigenesis (Yu & Jove, 2004). It is, therefore, unsurprising that STAT3 activity
is increased in a broad spectrum of human cancers and cancer cell lines (Buettner et al, 2002).
Additionally, in lung, breast, ovarian, pancreatic, and prostate cancer cell lines, hypoxia induced
STAT3 activation (Noman et al, 2009; Pawlus et al, 2014; Selvendiran et al, 2009; Gray et al,
2005). These lines of evidence suggest that STAT3 allows for cellular adaptation to hypoxia by
promoting the expression of proteins needed for survival in a low oxygen microenvironment.

Hypoxia and human opioid receptors
In addition to the role that STAT3 plays in promoting cellular adaptation to hypoxic
conditions, the human mu and delta opioid receptors (hMOR and hDOR) have also been
implicated in cancer progression (Singleton et al, 2015; Debruyne et al, 2010). Opioid receptor
agonists, such as morphine, are widely used analgesics that are frequently a part of cancer-related
pain management (Caraceni et al, 2012). Therefore, understanding the contribution that these
receptors make to cancer progression is very clinically relevant. However, this research effort
10

has yielded somewhat contradictory results, possibly due to dosage differences, differences in
route of administration, or differences between model system being used (Gach et al, 2011). For
example, in cultured human neuroblastoma cells, hMOR activity promoted cancer cell survival
by inhibiting apoptosis (Iglesias et al, 2003), while in cultured human glioma cells, inhibition of
hDOR lead to an increase in apoptosis and a decrease in cell proliferation (Zhou et al, 2013).
Conversely, several anti-tumor effects have also been attributed to hMOR activity. In
Lewis lung carcinoma cells xenografted into nude mice, hMOR activity suppressed
angiogenesis, leading to an increase in tumor cell apoptosis (Koodie et al, 2010). Hatsukari et al
also showed that morphine induced apoptosis in leukemia and adenocarcinoma cell lines, while
contributing to increased necrosis in a breast cancer cell line (2007). These effects were
diminished following naloxone (an opioid receptor antagonist) administration, suggesting that
one or more opioid receptor was responsible for the increased apoptotic activity. Therefore,
establishing a model of chemically inducible hypoxia within a neuronal cancer cell line that
naturally expresses stable opioid receptor levels has the potential to reveal how these receptors
participate in tumor cell adaptation to hypoxia.

Chemically induced models of hypoxia
Cellular hypoxia can be modeled using hypoxia mimetic compounds such as
desferoxamine (DFO), cobalt chloride (CoCl2), and nickel chloride (NiCl2). Through somewhat
different mechanisms, these compounds stabilize intracellular HIF by interfering with its
proteasomal degradation (Ren et al, 2000; Yuan et al, 2003; Davidson et al, 2006). This allows
HIF to accumulate within the cell and promote a hypoxic cellular phenotype. These hypoxia
mimetic systems are experimentally advantageous as compared to culturing cells under “true”
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hypoxic conditions (e.g. hypoxia chamber) because they are quicker to employ and are not
susceptible to reoxygenation during the course of the experiment (Wu & Yotnda, 2011).
Cobalt has been used in numerous studies as a way of simulating a hypoxic cellular
environment (Lee et al, 2001; Naves et al, 2013). Additionally, cobalt treatment induces reactive
oxygen species (ROS) generation and has been shown to induce cell death in neuroblastoma and
other cancer cell lines (Leonard et al, 2004; Stenger et al, 2011; Ardyanto et al, 2006). These
effects of cobalt are well established, however its effects in cells that survive treatment and the
cellular responses involved in enabling their survival are less clearly defined. And, while tumor
hypoxia has been the focus of thorough study, and some of the key cellular response elements
have been determined, many of the mechanisms underlying hypoxia-induced neuronal cellular
changes have yet to be elucidated (Span & Bussink, 2015). In order to answer some of these
questions, we used cobalt to model hypoxia in a human neuroblastoma cell line in order to study
the adaptive responses that occurred in cells that survived this chemically induced hypoxia.
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Materials and Methods
Cell culture
Human neuroblastoma (NMB) cells were grown in 75cm2 tissue culture flasks (VWR,
Radnor, PA), and provided with RPMI-1640 (Sigma-Aldrich, St. Louis, MO) supplemented with
10% heat-inactivated fetal bovine serum (Atlanta Biologicals, Flowery Branch, GA) in a 5%
CO2-95% air, humidified incubator at 37°C. Cells were maintained with 0.05mg of Gentamicin
Reagent/mL of medium (Life Technologies, Grand Island, NY) and 100 units of Penicillin
Streptomycin/mL (Life Technologies) of medium.

Cobalt chloride treatment
Cells were treated with 300µM cobalt chloride for 24 or 48hrs. For dose response assays,
cobalt chloride was administered to cells at final concentrations of 100, 300, and 500µM for
24hrs.

Flow cytometry
Control and cobalt-treated cells were washed to remove dead cells with serum-free
RPMI, gently harvested with 0.25% trypsin-EDTA (1X) (Life Technologies), centrifuged, and
resuspended in cold DPBS. NMB cells were fixed using BD Cytofix-Fixation Buffer, and then
resuspended in FACS buffer (2% FBS, 20% Versene in DPBS). Cell membranes were
permeabilized with BD Phosflow-Perm Buffer III. Permeabilized cells were stained in the dark at
4°C using BD flow antibodies against pY705-STAT3 (Lot#4330520) tagged with Alexa Fluor
647 and total STAT3 (Lot#4106912) tagged with allophycocyanin (APC). Following incubation
with stain, cells were centrifuged, excess stain was aspirated, and cells were resuspended in
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FACS buffer. Fluorescent emission measurements were made in triplicate using a MACSQuant
Analyzer (Miltenyi Biotech, Bergisch Gladbach, Germany) with lasers set to excite APC and
Alexa Fluor 647 fluorophores. Analysis of flow cytometry data was performed using FlowJo
(Ashland, OR).

Trypan Blue Exclusion Assay
Aliquots of live NMB cell suspensions that were harvested for flow cytometry protocol
were used to determine relative cell viability. Briefly, control and cobalt-treated cells were
stained (1:1 ratio) with Trypan Blue (Sigma-Aldrich) and the number of cells in each condition
that excluded the dye was counted. Cell viability was expressed as percent of control.

RNA extraction and RT-PCR
Total RNA was extracted from NMB cells using TriReagent (Molecular Research Center,
Cincinnati, OH). Extracted RNA was precipitated using chloroform and washed with cold 75%
ethanol. RNA concentrations were measured at 260nm using a Beckman-Coulter UV/Vis
Spectrophotometer. First strand cDNA synthesis was performed using random hexamer primers
(Promega, Madison, WI) and a GeneAmp PCR System (Applied Biosystems), using the
parameters: 37°C for 50 min, 70°C for 15 min. cDNA was stored at -80°C .

PCR and DNA gel electrophoresis
Equivalent quantities of total cDNA were added to each PCR reaction mixture. PCR
amplifications of hMOR and hDOR were achieved by using human-specific primers: hMOR 5’CTG GAA GGG CAG GGT ACT GGT GG-3’ and 5’-CTG CCC CCA CGA ACG CCA GCA
AT-3’; hDOR 5’- GTT CAC CAG CAT CTT CAC GCT C and 5′-CGG TCC TTC TCC TTG
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GAG CCC-3′. Parameters for PCR amplification of hMOR and hDOR were 95°C for 1 min,
68°C for 30 sec (32 cycles for MOR; 25 cycles for DOR), 72°C for 30 sec. Human-specific βactin primers (5′-CCT TCC TGG GCA TGG AGT CCT G-3′ and 5′-TAC AGC GAG GCC
AGG ATG G-3′) were added as a loading control for 18 cycles. PCR products were run on 2%
agarose/TAE gels containing ethidium bromide. Following electrophoresis, DNA gels images
were taken under UV light with AlphaImager. The fluorescent intensities of target and hβ-actin
bands were quantified using ImageQuant 5.2. Relative expression levels were normalized to
mean hβ-actin signal and expressed as percent of control.

Confocal microscopy
NMB cells grown on coverslips were stained for mitochondrial membrane potential
(ΔΨM) by incubating JC-1 dye (Cayman Chemical, Ann Arbor, MI) (1:100) at 37°C in the dark
for 30min. After incubation, the coverslips were washed twice with RPMI. Cells were imaged at
60X using a laser scanning confocal microscope (Fluoview 1000, Olympus, Tokyo, Japan) with
488 and 543nm lasers to detect FITC and Rhodamine Red X signals. As a positive control, cells
were treated with 10µM carbonyl cyanide 3-chlorophenylhydrazone (CCCP), a protonophore.

Confocal image analysis
A Rhodamine Red X filter was used to detect concentrated regions of J-aggregates and
hyperpolarized ΔΨM on the red channel. Simultaneously, a FITC filter was used to detect regions
of diffuse, non-aggregated JC-1 staining and depolarized ΔΨM on the green channel. Fluorescent
intensities from both channels were measured using the line ROI tool in FV10-ASW software
(Olympus). The ratio of average red channel (CHS2) signal/ average green channel (CHS1)
signal for each ROI was calculated and compared.
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Statistical analysis
Statistical analysis was carried out using GraphPad Prism 5 with unpaired Student’s ttest. Results were considered significant if p<0.05.
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Results
This study sought to establish a model of chemically induced hypoxia within a neuronal
cell line. Specifically, cobalt chloride was used to generate a hypoxic phenotype within a
neuroblastoma (NMB) cell line. Following 24 or 48hr cobalt treatment the surviving NMB cells
and their hypoxia-related changes were analyzed. The results provide a foundation for use of this
hypoxia model system in additional experiments aimed at unraveling the effect of hypoxia in
neuronal cancers.

Cobalt treatment decreased NMB cell viability
In order to establish a model system of cobalt-induced hypoxia within the NMB cell line,
we first determined how cobalt administration affected overall cell viability. We used Trypan
Blue to stain cell populations treated with increasing concentrations of cobalt for 24 or 48hrs to
assess the viability of cells. Unviable cells retained Trypan Blue, while viable, living cells
resisted the dye. By counting the number of unstained cells with a hemocytometer we
determined the cell viability in each treatment condition. These measurements were then
converted into percent of control (untreated cells).
Following 24hr treatment of NMB cells with an increase of cobalt concentrations, a
significant dose-dependent effect on cell viability (Fig. 1) was observed. Treatment with 100µM
cobalt decreased cell viability by ~34% (mean ~66% viability), 300µM decreased cell viability
by ~52% (mean ~48% viability), and 500µM decreased cell viability by ~60% (mean ~40%
viability). Since, 300µM cobalt treatment was sufficient to induce 50% cell death, we used this
concentration to induce hypoxia in all other experiments.

17

NMB cells treated with 300µM cobalt also resulted in a significant decrease of cell
viability in a time-dependent manner (Fig. 2). Twenty-four hour treatment resulted in ~30%
decrease (~69% mean viability), while 48hr treatment decreased the mean cell viability to ~39%
(~60% decrease) as compared to control. Regardless of treatment duration or concentration, there
were still surviving neurons (Fig. 3), which were then used to study the adaptive responses.
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Figure 1: NMB cells treated with cobalt for 24hrs significantly decreased cell viability in a dose-dependent manner
as compared to control. Values represent the mean cell counts +/- SEM and are expressed as percent of control.
Significance was determined using unpaired Student’s t-test; ***p<0.0001.
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Figure 2: Cobalt treatment caused a time-dependent significant decrease in NB cell viability as compared to control.
Values represent mean (+/- SEM) hemocytometer counts and are expressed as percent of control. Significance
determined by unpaired Student’s t-test; *p<0.05, ***p<0.001.
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Cobalt treatment changed NMB cell morphology
Hypoxia has been associated with morphological changes in murine neocortical neurons
and human mesenchymal stem cells (Park et al, 1996; Zeng et al, 2011). Therefore, we examined
NMB morphology under cobalt -induced hypoxia.
Along with the visual increase in the proportion of dead cells present in the treatment
conditions, there was also a clear visual change in the morphology of the treated cells. Cells
became more pronounced with 48hr cobalt treatment (Fig. 3), as compared to control cells,
which were smaller and more rounded. A proportion of treated cells displayed elongated
neuronal processes.
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Figure 3: Treatment of NB cells with cobalt increased the length of neuronal processes (marked with red arrows),
and the proportion of cells that displayed these processes. Also in these images is the increased number of dead cells
in the 24 and 48hr treatment conditions.
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Cobalt treatment did not affect ΔΨM of surviving NMB cells
Previous research has implicated that cobalt treatment can result in mitochondrial
membrane potential (ΔΨM) collapse in human glioblastomas (Zeno et al, 2009). To determine if
cobalt treatment can cause the depolarization of mitochondrial membrane potential, we therefore
used laser scanning confocal microscopy to gauge differences in ΔΨM in NMB mitochondria
labeled with a dichromatic ratiometric dye, JC-1. JC-1 dye has been used for this application in
numerous studies and cell lines (Diaz et al, 1999; Perry et al, 2011). Briefly, JC-1 dye can exist
within living cells in two forms, green monomeric form and red aggregate form. The red JC-1
aggregates accumulate in hyperpolarized (negatively charged) mitochondria, while green
monomeric JC-1 highlights depolarized (more positively charged) mitochondria. In order to
make qualitative and semi-quantitative measurements of ΔΨM, JC-1-dyed control and treated
cells were stimulated using both 488 and 543 nm lasers and signals were detected with FITC
(channel 1, CHS1) and Rhodamine Red X (channel 2, CHS2) filters. The ratio CHS2/CHS1 of
each acquired image was calculated as a semi-quantitative measurement of ΔΨM.
We found that 24 or 48hr cobalt treatment does not significantly affect CHS2/CHS1 ratio
as compared to that of control cells (Fig. 4). The mean CHS2/CHS1 value (expressed as percent
of control) for 24hr cobalt treatment was ~98% and for 48hr treatment the mean value was
~97%. In order to demonstrate that JC-1 staining was sensitive to changes in ΔΨM, NMB
mitochondria were purposefully depolarized using the protonophore, carbonyl cyanide 3chlorophenylhydrazone (CCCP). In control cells incubated with JC-1 dye and CCCP, ΔΨM was
significantly depolarized, leading to a quantitative decrease in the CHS2/CHS1 ratio. Visually,
CCCP treatment resulted in a lack of accumulation of red JC-1 aggregates in depolarized
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mitochondria with only diffuse green staining. Additionally, the elongated neuronal processes of
treated NMB cells that were highlighted in Fig. 3 were also evident under confocal microscopy.
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Figure 4: Mitochondrial membrane potential (ΔΨM), as assessed by JC-1 ratiometric dye, is not affected by cobalt
treatment. Mean values (+/- SEM) of the CHS2 (red channel)/CHS1 (green channel) ratios for control, 24hr Co, and
48hr Co, and CCCP. Significance was determined using unpaired Student’s t-test; ***p<0.0001.
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Analysis of STAT3 factor
STAT3 is a transcription factor that requires phosphorylation of its tyrosine 705 (Y705)
to translocate to the nucleus and regulate gene expression (Calo et al, 2003). Once activated,
STAT3 promotes the expression of anti-apoptotic proteins such as Bcl-XL, survivin, and Mcl-1,
cell cycle promoters including c-Myc and cyclin D1, and angiogenic proteins including VEGF
(Ouédraogo et al, 2015). The role of STAT3 as a transcription factor for several proteins
involved in the cellular response to hypoxia suggests that STAT3, especially phosphotyrosine
STAT3 (pY705-STAT3), may be modulated by hypoxia. Furthermore, it has been demonstrated
that phosphorylated STAT3 increases in response to cobalt stimulation in both adenocarcinoma
and prostate carcinoma cell lines (Gray et al, 2005). In order to determine the role of STAT3 in
cobalt treated neuronal cells, flow cytometry was used to analyze changes in total STAT3 levels
and changes in the amount of phosphorylation at its Y705 residue in these surviving neurons.

Cobalt treatment increased total STAT3
Control and cobalt treated cells were stained for total STAT3 protein using anti-STAT3
antibody tagged with allophycocyanin (APC) and analyzed using flow cytometry. All cell
populations were gated on the parameters of forward scatter vs. side scatter (FSC vs. SSC) to
exclude any remaining dead cells and/or cellular debris. The parameters of SSC vs. STAT3
fluorescence signal were then used to plot histograms.
Flow cytometry analysis of cobalt-treated cells revealed that these cells significantly
increased their total level of STAT3 over 48hr treatment duration as compared to control cells
(Fig. 5A). Twenty-four hour treatment resulted in a mean increase in total STAT3 of ~7% and
48hr treatment resulted in a significant mean increase in total STAT3 of ~13%. The increase in
total STAT3 levels in treated cells is shown in the panel of histograms in Fig. 5B, as duration
26

increases and the fluorescent signal becomes more intense. This shift in STAT3 fluorescence
indicates that treated cells had an increased amount of total STAT3 as compared to that of
control cells.
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Figure 5: NMB cells significantly increased the amount of total STAT3 expressed over 48hr cobalt treatment. (A)
Mean values (+/- SEM) of fluorescent intensities expressed as percent of control. Significance was determined using
unpaired Student’s t-test; *p<0.05. (B) Histograms from a single set of representative measurements in which the
mean fluorescent intensity increased as a result of cobalt treatment. Y-axis is normalized to area under the curve. Xaxis is fluorescent intensity (log5 scale).
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Cobalt treatment decreased pY705-STAT3
Interestingly, the preliminary data showed that pY705-STAT3 levels were significantly
decreased under various cobalt exposures (Fig. 6A). The same gating parameters (FSC vs. SSC)
were used to include only intact cells. As compared to control, 24hr cobalt treatment
significantly decreased the mean pY705-STAT3 signal to ~84% and 48hr treatment resulted in a
decrease to a mean of ~74%. The histogram panel in Fig. 6B shows a time-dependent leftward
shift in fluorescent intensity of pY705-STAT3. These preliminary data showed that total STAT3
level increased as the treatment duration increased, whereas STAT3 activation via Y705
decreased in response to cobalt challenge.
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Figure 6: Cobalt treatment significantly decreased NMB pY705-STAT3 levels in a time dependent manner. (A)
Mean values (+/- SEM) of fluorescent intensities expressed as percent of control. Significance was determined using
unpaired Student’s t-test; **p<0.01, ***p<0.0001. (B) Histograms from a single set of representative measurements
in which the mean phosphotyrosine signal decreased as a result of cobalt treatment. Y-axis is normalized to area
under the curve. X-axis is fluorescent intensity (log5 scale).
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Effect of cobalt treatment on hMOR and hDOR expression
NMB cells express all three endogenous opioid receptors (Baumhaker et al, 1994). As
such, NMB cells are an ideal cell line for observing the cobalt-induced hypoxic effect on hMOR
and hDOR expression. The preliminary data from RT-PCR analysis showed that NMB cells
decreased expression of hMOR (Fig. 7) under the treatment. As compared to control, 24hr cobalt
treatment resulted in a 54% decrease of hMOR expression, and 48hr treatment caused an 80%
decrease in mean hMOR expression. There was no detectable change in hDOR expression as
compared to that of control (Fig. 8).

31

Figure 7: hMOR expression decreased in NMB cells that survived cobalt treatment. The hMOR PCR product was
analyzed using gel electrophoresis. The band intensities were normalized to mean hβ-actin signal. The data is
expressed as the percent of control.
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Figure 8: NMB hDOR expression did not change in response to cobalt treatment. The hDOR PCR product was
analyzed using gel electrophoresis. The band intensities were normalized to hβ-actin signal. The data is expressed as
the percent of control.
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Discussion
Hypoxia is a common feature of many solid tumors and can contribute to tumor
progression, tumoral resistance to therapy, metastasis, and a poor clinical outcome. The causes of
tumor hypoxia are well understood, but little research has been done on understanding the effects
of hypoxia within a neuronal cancer cell line. Specifically, some of the factors that contribute to
cell survival under hypoxic conditions are not fully understood. In order to address these
questions, we established the basis for a model of chemically induced hypoxia using NMB cells
with the hypoxia mimetic cobalt chloride. Utilizing this model, this study demonstrated that
hMOR expression was decreased while an increase in total STAT3 accompanied by decreased
phosphorylation at Y705 was detected.
By measuring significant decreases in overall NMB cell viability as a function of the
duration and concentration of cobalt treatment, we established that this cell line is responsive to
this hypoxia mimetic agent. These results agree with previous studies that show that cobalt
chloride negatively affects cell viability. Cobalt has been reported to promote apoptosis in
different cell lines, such as human acute myeloid leukemic cells, mouse embryonic fibroblasts,
and human carcinoma cells (Huang et al, 2003; Vengellur & LaPres, 2004; Ardyanto et al,
2006). However, whether cobalt treatment can promote apoptosis in this NMB cell model system
will need to be further investigated. Additionally, we detected distinct morphological changes
that were characterized by elongation of neuronal processes in cobalt-treated cells. Other studies
have also observed similar changes in cell morphology in response to cobalt hypoxia mimetic
using mesenchymal stem cells (Zeng et al, 2011) and colon cancer cells (Lopez-Sanchez et al,
2014). Cobalt-induced morphological changes to neuronal cancer cells have not been previously
reported.
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In rat PC12 neuronal cells cobalt chloride induced apoptosis, which is accompanied by
and likely initiated by a loss of mitochondrial membrane potential (ΔΨM) (Jung & Kim, 2004;
Jung et al, 2007). Using a similar method of measuring ΔΨM, we did not observe a change in
ΔΨM of the surviving neurons. This discrepancy is actually unsurprising, as these surviving cells
developed the adaptive responses under cobalt-induced hypoxia. To determine if ΔΨM disruption
also causes apoptosis in NMB cells additional experiments will need to be performed that
include apoptotic cells.
Given that some cobalt-treated cells experience a loss of ΔΨM before succumbing to
apoptosis, it is possible that a resistance to cellular events that otherwise would induce proapoptotic ΔΨM changes, which we observed in surviving and attached cells, is part of the
mechanism that allows some NMB cells to adapt to hypoxia. In fact, another group has recently
demonstrated that apoptosis-resistant prostate and colon cancer cells preserved mitochondrial
functionality as well as ΔΨM even after long-term hypoxia stimulation (Chiche et al, 2010). This
report, as well as our results, suggest that a contributing factor of cancer cell adaptation to
hypoxia may be the ability of some cell mitochondria to resist ΔΨM disruption, thereby
forestalling apoptosis. More investigation will need to be performed to confirm this hypothesis,
and to explore intracellular factors that may be responsible for mediating this mitochondrial
activity.
An additional factor that may mediate NMB adaptation to cobalt-induced hypoxia is
STAT3. In preliminary results, we observed a time-dependent increase in total STAT3 in
response to cobalt administration, suggesting its involvement in the adaptive processes.
Classically, STAT3 activation occurs via Y705 phosphorylation, which induces STAT3
homodimerization and directs it to the nucleus where it acts as a transcription factor for several
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oncogenic cellular processes. Given that, membrane bound receptor tyrosine kinases, cytokine
receptor-associated Janus Kinases (JAKs), and non-receptor tyrosine kinases have all been
shown to phosphorylate Y705-STAT3 (Brantley & Benveniste, 2008), Y705-STAT3 is
positioned as an intracellular node through which multiple signals are interpreted and passed.
However, this study showed a decrease in the amount of phosphotyrosine STAT3 in a timedependent manner in response to cobalt administration, suggesting that STAT3 activation via
Y705 may not be involved in NMB adaptation to hypoxia. While these results need to be
repeated and corroborated with different methods, they point to a role for STAT3 in response to
cobalt-induced hypoxia that is not mediated via its critical tyrosine residue in this NMB cell
model system.
Recently, several phosphotyrosine-independent roles for STAT3 have been proposed.
These include maintaining ΔΨM, reducing ROS production, and mediating Ras-induced
oncogenic transformation (Yan & Rincon, 2016). In order to promote these cellular processes
mitochondrial localization of STAT3 and phosphorylation of its serine residue (S727) are
required (Wegrzyn et al, 2009; Gough et al, 2009; Zhang et al, 2013). Disruption of ΔΨM and
ROS generation are two well-documented effects of CoCl2 administration (Jung & Kim, 2004;
Leonard et al, 2004). Therefore, S727 phosphorylation may also be involved in the development
of adaptation. Taken together, this study along with various reports may implicate a bifurcated
pathway of STAT3 activity: a classical pathway in which Y705 phosphorylation leads to STAT3
nuclear translocation and transcription regulation and a non-classical/mitochondrial pathway,
which has been reported in both pancreatic cancer cells and glioma cells (Kang et al, 2012;
Mandal et al, 2014).
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Independent of the role of STAT3, this study also sought to clarify functions of hMOR
and hDOR in response to cobalt-induced hypoxia. The endogenous expression of all three major
opioid receptors in this NMB cell line made it ideal for measuring their expression changes
under cobalt treatment. The preliminary RT-PCR data showed a time-dependent decrease in
hMOR expression, while hDOR expression remained unchanged. These results point to a
possible antagonistic function of hMOR in NMB survival, while also suggesting that hDOR may
or may not be involved in the NMB response to hypoxia. Similar findings were also reported
previously using the same NMB cell line with the hypoxia mimetic DFO (Cook et al, 2010;
Candelora, 2014).
Overall, this study reported that the development of adaptive responses, including
elongation of neuronal processes, increased levels of STAT3 and of hMOR expression, and
decreased phosphorylation of Y705-STAT3, in surviving NMB cells under cobalt-induced
hypoxia. Additional data sets will be added to further validate these preliminary results. Given
that mechanistic differences between chemically induced hypoxia and “true” hypoxia exist
(Huang et al, 2014), it will be useful to examine these adaptive response under actual low oxygen
conditions in the future.
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